Recent Finacing
Recent Raise
Revel Pharmaceuticals develops repair-focused designer enzymes and an enzyme platform to degrade damage in aging-related diseases, advancing programs into clinical development for osteoarthritis, kidney, cardiovascular, skin, and diabetic complications.
Focus Areas
Recent Investors
Total Raised
Funding round
Investors
